Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia:: is this the real target?

被引:12
|
作者
Malagola, M [1 ]
Martinelli, G [1 ]
Rondoni, M [1 ]
Paolini, S [1 ]
Gaitani, S [1 ]
Arpinati, M [1 ]
Piccaluga, PP [1 ]
Amabile, M [1 ]
Basi, C [1 ]
Ottaviani, E [1 ]
Candoni, A [1 ]
Gottardi, E [1 ]
Cilloni, D [1 ]
Bocchia, M [1 ]
Saglio, G [1 ]
Lauria, F [1 ]
Fanin, R [1 ]
Visani, G [1 ]
Marré, MC [1 ]
Maderna, M [1 ]
Rancati, F [1 ]
Vinaccia, V [1 ]
Russo, D [1 ]
Baccarani, M [1 ]
机构
[1] Policlin S Orsola, Inst Hematol & Med Oncol L & A Seragnoli, I-40138 Bologna, Italy
关键词
D O I
10.1182/blood-2004-08-3088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:904 / 904
页数:1
相关论文
共 50 条
  • [41] Trisomy 8 finding treatment of imatinib mesylate in chronic myeloid leukemia cases
    Tunca, Y
    Güran, S
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (02) : 151 - 151
  • [42] Results of imatinib mesylate therapy in chronic myeloid leukemia
    Altintas, Abdullah
    Cil, Timucin
    Ayyildiz, Orhan
    Kaplan, Mehmet A.
    Isikdogan, Abdurrahman
    Muftuoglu, Ekrem
    Atay, Ahmet E.
    ANNALS OF ONCOLOGY, 2006, 17 : 211 - 211
  • [43] Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia
    Katsuro Ito
    Kazunori Tominaga
    Toshiya Suzuki
    Itsuro Jinnai
    Masami Bessho
    International Journal of Hematology, 2005, 81 : 242 - 245
  • [44] Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia
    Ito, K
    Tominaga, K
    Suzuki, T
    Jinnai, I
    Bessho, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (03) : 242 - 245
  • [45] The unfolding story of imatinib mesylate for chronic myeloid leukemia
    Goldman, John M.
    ONCOLOGY-NEW YORK, 2007, 21 (06): : 663 - 664
  • [46] Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate
    Ribera, JM
    Oriol, A
    Gonzalez, M
    Vidriales, MB
    Xicoy, B
    Grau, J
    Esteve, J
    Brunet, S
    Del Potro, E
    Moreno, MJ
    Tormo, M
    Martin-Reina, MV
    Deben, G
    Parody, R
    Lahuerta, UJ
    San Miguel, JF
    BLOOD, 2004, 104 (11) : 203B - 204B
  • [47] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation
    T Nanri
    N Matsuno
    T Kawakita
    H Mitsuya
    N Asou
    Leukemia, 2005, 19 : 1673 - 1675
  • [48] Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
    Thomas, DA
    Faderl, S
    Cortes, J
    O'Brien, S
    Giles, FJ
    Kornblau, SM
    Garcia-Manero, G
    Keating, MJ
    Andreeff, M
    Jeha, S
    Beran, M
    Verstovsek, S
    Pierce, S
    Letvak, L
    Salvado, A
    Champlin, R
    Talpaz, M
    Kantarjian, H
    BLOOD, 2004, 103 (12) : 4396 - 4407
  • [49] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and C-KIT exon 8 mutation
    Asou, N
    Nanri, T
    Matsuno, N
    Kawakita, T
    Suzushima, H
    Mitsuya, H
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 75 - 75
  • [50] Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation
    Nanri, T
    Matsuno, N
    Kawakita, T
    Mitsuya, H
    Asou, N
    LEUKEMIA, 2005, 19 (09) : 1673 - 1675